Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Depreciation & Amortization (CF): 2011-2025

Historic Depreciation & Amortization (CF) for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $138,000.

  • Sonoma Pharmaceuticals' Depreciation & Amortization (CF) fell 12.35% to $71,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $268,000, marking a year-over-year decrease of 17.79%. This contributed to the annual value of $138,000 for FY2025, which is 21.59% down from last year.
  • Sonoma Pharmaceuticals' Depreciation & Amortization (CF) amounted to $138,000 in FY2025, which was down 21.59% from $176,000 recorded in FY2024.
  • Sonoma Pharmaceuticals' Depreciation & Amortization (CF)'s 5-year high stood at $227,000 during FY2021, with a 5-year trough of $125,000 in FY2023.
  • In the last 3 years, Sonoma Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $138,000 in 2025 and averaged $146,333.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 32.80% in 2023, then surged by 40.80% in 2024.
  • Sonoma Pharmaceuticals' Depreciation & Amortization (CF) (Yearly) stood at $227,000 in 2021, then declined by 18.06% to $186,000 in 2022, then plummeted by 32.80% to $125,000 in 2023, then surged by 40.80% to $176,000 in 2024, then declined by 21.59% to $138,000 in 2025.